CN Patent
CN111249229B — 一种稳定的法匹拉韦注射液及其制备方法
Assigned to Beijing Fukangren Bio Pharm Tech Co Ltd · Expires 2023-05-02 · 3y expired
What this patent protects
一种稳定的法匹拉韦注射液及其制备方法,该发明包含法匹拉韦和增溶剂磺丁基醚‑β‑环糊精钠,还可以包含酸碱调节剂,该发明可耐受终端灭菌,安全性,稳定性良好。
USPTO Abstract
一种稳定的法匹拉韦注射液及其制备方法,该发明包含法匹拉韦和增溶剂磺丁基醚‑β‑环糊精钠,还可以包含酸碱调节剂,该发明可耐受终端灭菌,安全性,稳定性良好。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.